<DOC>
	<DOCNO>NCT00006248</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient metastatic recurrent head neck cancer .</brief_summary>
	<brief_title>S0007 - Combination Chemotherapy Treating Patients With Metastatic Recurrent Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine overall survival patient metastatic recurrent squamous cell carcinoma head neck treat paclitaxel , cisplatin , fluorouracil . - Determine response ( unconfirmed , confirm , complete , partial ) time treatment failure patient measurable disease treat regimen . - Determine toxic effect regimen patient . OUTLINE : Patients receive paclitaxel IV 3 hour follow cisplatin IV 30 minute day 1 fluorouracil IV 24 hour day 1-4 . Courses repeat every 21 day absence disease progression unacceptable toxicity . Patients achieve complete response ( CR ) receive 3 additional course beyond CR . Patients follow every 3 month 1 year every 6 month 2 year . PROJECTED ACCRUAL : A total 65 patient accrue study within 12 month .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck Metastatic diagnosis persistent , metastatic , recurrent surgery and/or radiotherapy Relapse prior induction adjuvant therapy allow No newly diagnose nonmetastatic disease Measurable nonmeasurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 50 mL/min Other : Not pregnant nursing Fertile patient must use effective contraception No grade 2 great sensory neuropathy No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , stage I II cancer complete remission PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy Chemotherapy : See Disease Characteristics At least 6 month since prior carboplatin cisplatin induction adjuvant chemotherapy No 1 prior induction adjuvant chemotherapy regimen No prior chemotherapy recurrent newly diagnose metastatic disease No concurrent chemotherapy Endocrine therapy : No concurrent anticancer hormonal therapy Radiotherapy : See Disease Characteristics At least 28 day since prior radiotherapy recover No concurrent radiotherapy Surgery : See Disease Characteristics At least 28 day since prior surgery recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>